Key Points
- Amir Heshmatpour, Neonc's president, purchased 10,000 shares on April 28 at an average price of $4.52, raising his stake to 3,062,000 shares (a 0.33% increase) valued at about $13.84M.
- Analyst coverage is mixed: BTIG initiated a Buy with a $15 target, Zacks rates it Hold, Weiss Ratings keeps a Sell (e+), and the MarketBeat consensus is Hold with an average price target of $15.
- Institutional interest is growing—firms like HighPoint Advisor Group and Vanguard have increased or initiated positions—while the stock trades around $4.31 with a 52‑week range of $3.20–$12.99.
Neonc Technologies Holdings, Inc. (NASDAQ:NTHI - Get Free Report) President Amir Heshmatpour acquired 10,000 shares of the company's stock in a transaction dated Tuesday, April 28th. The stock was acquired at an average price of $4.52 per share, with a total value of $45,200.00. Following the purchase, the president owned 3,062,000 shares in the company, valued at approximately $13,840,240. This represents a 0.33% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.
Neonc Technologies Stock Performance
Shares of NTHI stock opened at $4.31 on Wednesday. Neonc Technologies Holdings, Inc. has a 52-week low of $3.20 and a 52-week high of $12.99. The firm has a fifty day moving average of $7.37 and a 200-day moving average of $8.53.
Wall Street Analysts Forecast Growth
NTHI has been the subject of a number of recent research reports. BTIG Research initiated coverage on shares of Neonc Technologies in a research note on Friday. They issued a "buy" rating and a $15.00 price objective for the company. Zacks Research upgraded shares of Neonc Technologies to a "hold" rating in a research note on Wednesday, January 14th. Finally, Weiss Ratings restated a "sell (e+)" rating on shares of Neonc Technologies in a research note on Friday, March 27th. One research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Hold" and an average price target of $15.00.
Check Out Our Latest Stock Analysis on NTHI
Institutional Investors Weigh In On Neonc Technologies
Several large investors have recently made changes to their positions in NTHI. HighPoint Advisor Group LLC lifted its holdings in Neonc Technologies by 20.5% during the 4th quarter. HighPoint Advisor Group LLC now owns 1,144,640 shares of the company's stock valued at $9,466,000 after purchasing an additional 194,408 shares during the last quarter. Bank of America Corp DE grew its stake in Neonc Technologies by 1.0% during the third quarter. Bank of America Corp DE now owns 226,486 shares of the company's stock worth $2,056,000 after buying an additional 2,207 shares during the last quarter. Vanguard Group Inc. bought a new stake in Neonc Technologies during the third quarter worth about $1,279,000. 683 Capital Management LLC bought a new stake in Neonc Technologies during the fourth quarter worth about $442,000. Finally, Global Retirement Partners LLC bought a new stake in Neonc Technologies during the third quarter worth about $434,000.
Neonc Technologies Company Profile
(
Get Free Report)
Neonc Technologies Holdings, Inc develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
